499 related articles for article (PubMed ID: 23723198)
1. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
[TBL] [Abstract][Full Text] [Related]
2. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation.
Mori Y; Miyamoto T; Nagafuji K; Kamezaki K; Yamamoto A; Saito N; Kato K; Takenaka K; Iwasaki H; Harada N; Abe Y; Teshima T; Akashi K
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1596-602. PubMed ID: 20685258
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
[TBL] [Abstract][Full Text] [Related]
4. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
[TBL] [Abstract][Full Text] [Related]
6. HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.
Inazawa N; Hori T; Yamamoto M; Hatakeyama N; Yoto Y; Nojima M; Yasui H; Suzuki N; Shimizu N; Tsutsumi H
J Med Virol; 2016 Feb; 88(2):319-23. PubMed ID: 26241219
[TBL] [Abstract][Full Text] [Related]
7. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.
Ogata M; Satou T; Kawano R; Takakura S; Goto K; Ikewaki J; Kohno K; Ikebe T; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Saikawa T; Kadota J
Bone Marrow Transplant; 2010 Jan; 45(1):129-36. PubMed ID: 19465942
[TBL] [Abstract][Full Text] [Related]
8. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
[TBL] [Abstract][Full Text] [Related]
9. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.
Ishiyama K; Katagiri T; Hoshino T; Yoshida T; Yamaguchi M; Nakao S
Bone Marrow Transplant; 2011 Jun; 46(6):863-9. PubMed ID: 20838386
[TBL] [Abstract][Full Text] [Related]
10. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis.
Shimazu Y; Kondo T; Ishikawa T; Yamashita K; Takaori-Kondo A
Transpl Infect Dis; 2013 Apr; 15(2):195-201. PubMed ID: 23331378
[TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.
Ogata M; Kikuchi H; Satou T; Kawano R; Ikewaki J; Kohno K; Kashima K; Ohtsuka E; Kadota J
J Infect Dis; 2006 Jan; 193(1):68-79. PubMed ID: 16323134
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
16. [Human Herpesvirus-6 Encephalitis in Allogeneic Hematopoietic Stem Cell Transplantation].
Ogata M
Brain Nerve; 2015 Jul; 67(7):919-30. PubMed ID: 26160819
[TBL] [Abstract][Full Text] [Related]
17. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.
Ogata M; Satou T; Kawano R; Goto K; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Saikawa T; Kadota JI
Bone Marrow Transplant; 2008 Feb; 41(3):279-85. PubMed ID: 18037945
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
Zerr DM; Corey L; Kim HW; Huang ML; Nguy L; Boeckh M
Clin Infect Dis; 2005 Apr; 40(7):932-40. PubMed ID: 15824982
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation.
Zerr DM
J Clin Virol; 2006 Dec; 37 Suppl 1():S52-6. PubMed ID: 17276370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
